Association between 3D membranous urethral parameters and urinary continence recovery after RARP

Table 2 Univariate and multivariate regression analysis of patients achieving continence 1 month after RARP and those who cannot

	Total	Patients achieving continence 1 month after RARP group		Patients failed to achieve continence 1 month after RARP group		P	Multivariate
	Total	Patients achieving continence 1 month after RARP group					OR	95%CI	P
No. of patients (%)	120	60 (50)		60 (50)
		Mean	SD	Mean	SD
Age (years)		68.10	6.09	70.48	5.04	0.021	0.964	0.893–1.041	0.356
BMI (kg/m²)		23.29	2.61	23.50	2.62	0.660
tMUV (mm³)		1416.99	470.98	1286.36	464.57	0.124
eMUV (mm³)		936.91	297.40	806.28	262.65	0.012	1.002	1.001–1.003	0.008
fMUL (mm)		19.01	2.58	18.37	2.65	0.065
eMUL (mm)		13.28	2.17	12.52	2.04	0.049	1.090	0.872–1.363	0.450
PV (cc)		35.83	27.51	36.20	19.29	0.220
VPSS		8.97	0.58	10.80	0.49	0.004	0.886	0.806–0.973	0.011

The statistically significant p values in the table are shown in bold
BMI body mass index, OR odd ratio, CI confidence interval, SD standard deviation, tMUV total membranous urethral complex volume, eMUV exposed membranous urethral complex volume, fMUL full membranous urethral length, eMUL exposed membranous urethral length, PV prostate volume, VPSS visual prostate symptom score

ISSN: 2047-783X